Ajanta Pharma USA Inc recalls Ranolazine Extended-Release Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- What's wrong
- Failed Dissolution Specifications: below specification
- Products
-
- Ranolazine Extended-Release Tablets
- Company
- Ajanta Pharma USA Inc
- Where it was sold
-
Nationwide in the US.
- Status
- Ongoing
Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.